Back to search

Article

<i>RRAS</i> and <i>RRAS2</i> mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236

2025-09-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> RRAS and RRAS2 encode a subfamily of RAS-like small GTPases that share considerable structural and functional similarities with KRAS , HRAS , and NRAS. Whether homologous RRAS / RRAS2 mutations are oncogenic and actionable drivers in lung cancer remains underexplored. <h4>Methods</h4> An institutional cohort of 8,488 non-small cell lung carcinomas (NSCLC) sequenced...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d48c57bf-ecdf-5bd6-ab47-08ff5c3d7177
DOI
10.1101/2025.09.19.677259
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>RRAS</i> and <i>RRAS2</i> mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236DOI 10.1101/2025.09.19.677259
Select a neighboring publication to make it the new centre.